X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (45) 45
index medicus (41) 41
female (34) 34
male (34) 34
middle aged (34) 34
hematology (31) 31
aged (29) 29
adult (28) 28
life sciences (24) 24
oncology (20) 20
lymphoma (16) 16
cancer (14) 14
retrospective studies (13) 13
adolescent (12) 12
aged, 80 and over (12) 12
treatment outcome (12) 12
lymphomas (11) 11
rituximab (11) 11
antineoplastic combined chemotherapy protocols - therapeutic use (10) 10
chemotherapy (10) 10
disease-free survival (10) 10
transplantation (10) 10
trial (10) 10
[ sdv.can ] life sciences [q-bio]/cancer (9) 9
neoplasm staging (9) 9
recurrence (9) 9
stem cell transplantation (9) 9
survival (9) 9
[sdv.can]life sciences [q-bio]/cancer (8) 8
hemic and lymphatic diseases (8) 8
prognosis (8) 8
response criteria (8) 8
young adult (8) 8
abridged index medicus (7) 7
antineoplastic combined chemotherapy protocols - administration & dosage (7) 7
bone-marrow-transplantation (7) 7
disease (7) 7
follow-up studies (7) 7
leukemia (7) 7
stem cells (7) 7
survival rate (7) 7
allografts (6) 6
care and treatment (6) 6
hematology, oncology and palliative medicine (6) 6
human health and pathology (6) 6
immune system diseases (6) 6
patients (6) 6
positron-emission-tomography (6) 6
prospective studies (6) 6
risk factors (6) 6
survival analysis (6) 6
therapy (6) 6
[sdv]life sciences [q-bio] (5) 5
allogeneic stem cell transplantation (5) 5
analysis (5) 5
antineoplastic combined chemotherapy protocols - adverse effects (5) 5
autografts (5) 5
france (5) 5
guidelines (5) 5
high-dose therapy (5) 5
hodgkin's disease (5) 5
lymphoma, mantle-cell - therapy (5) 5
mantle cell lymphoma (5) 5
remission induction (5) 5
transplantation, autologous (5) 5
[ sdv ] life sciences [q-bio] (4) 4
[sdv.mhep.hem]life sciences [q-bio]/human health and pathology/hematology (4) 4
acute myeloid-leukemia (4) 4
allogreffe (4) 4
bendamustine (4) 4
cytarabine - administration & dosage (4) 4
drug administration schedule (4) 4
drug resistance, neoplasm (4) 4
follow-up (4) 4
hematopoietic stem cell transplantation (4) 4
hematopoietic stem cell transplantation - standards (4) 4
hodgkin disease - drug therapy (4) 4
hodgkin disease - mortality (4) 4
hodgkin disease - therapy (4) 4
lymphoma, mantle-cell - drug therapy (4) 4
lymphoma, mantle-cell - mortality (4) 4
lymphome (4) 4
pet imaging (4) 4
positron-emission tomography (4) 4
randomized-trial (4) 4
recommandations (4) 4
societies, medical (4) 4
[ sdv.mhep.hem ] life sciences [q-bio]/human health and pathology/hematology (3) 3
age factors (3) 3
antimitotic agents (3) 3
antineoplastic agents (3) 3
antineoplastic agents - adverse effects (3) 3
bleomycin (3) 3
child (3) 3
combination (3) 3
combined modality therapy (3) 3
cyclophosphamide - administration & dosage (3) 3
diagnosis (3) 3
doxorubicin (3) 3
efficacy (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 09/2017, Volume 377, Issue 13, pp. 1250 - 1260
Journal Article
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, ISSN 1619-7070, 08/2017, Volume 44, Issue 8, pp. 1254 - 1257
Journal Article
European Journal of Nuclear Medicine and Molecular Imaging, ISSN 1619-7070, 08/2017, Volume 44, Issue 8, pp. 1254 - 1257
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 01/2013, Volume 31, Issue 1, pp. 104 - 110
Journal Article
European Journal of Nuclear Medicine and Molecular Imaging, ISSN 1619-7070, 10/2017, Volume 44, Issue 11, pp. 1937 - 1939
Journal Article
Leukemia, ISSN 0887-6924, 08/2018, Volume 32, Issue 8, pp. 1768 - 1777
Journal Article
Journal Article
British journal of haematology, ISSN 0007-1048, 08/2019
We analysed the outcomes of 62 patients with refractory/relapsed diffuse large B-cell lymphoma (rrDLBCL) who had pre-transplantation fluorodeoxyglucose... 
Journal Article
Haematologica, ISSN 0390-6078, 07/2012, Volume 97, Issue 7, pp. 1085 - 1091
Journal Article
Haematologica, ISSN 0390-6078, 11/2012, Volume 97, Issue 11, pp. 1751 - 1756
Journal Article
PLoS ONE, ISSN 1932-6203, 03/2017, Volume 12, Issue 3, pp. e0172147 - e0172147
The risk and clinical significance of cardiac iron overload due to chronic transfusion varies with the underlying disease. Cardiac iron overload shortens the... 
MORTALITY | SURVIVAL | RESONANCE | MORBIDITY | CHELATION-THERAPY | DEPENDENT PATIENTS | MULTIDISCIPLINARY SCIENCES | DISEASE | ACCUMULATION | BETA-THALASSEMIA | CHILDREN | Heart - physiopathology | Thalassemia - blood | Myelodysplastic Syndromes - physiopathology | Anemia, Sickle Cell - physiopathology | Humans | Middle Aged | Male | Myelodysplastic Syndromes - blood | Iron Overload - physiopathology | Iron Overload - blood | Blood Transfusion | Iron Chelating Agents | Myocardium - metabolism | Adolescent | Adult | Female | Anemia, Sickle Cell - blood | Thalassemia - physiopathology | Child | Iron - blood | Sickle cell anemia | Cardiac patients | Analysis | Thalassemia | Iron | Research | Health aspects | Myelodysplastic syndromes | Blood transfusions | Heart | Erythropoiesis | Pediatrics | Transferrin | Nuclear magnetic resonance--NMR | Transfusion | Laboratories | Liver | Ferritin | Disorders | Macrophages | Blood | Myelodysplastic syndrome | Red blood cells | Chelation | Hemoglobin | Sickle cell disease | Heart diseases | Age | Life expectancy | Hematology | Anemia | Research & development--R&D | Magnetic resonance | Inflammation | Patients | Coronary artery disease | Chromatography | Hospitals | Life span | Scientific imaging | Hepcidin | Mass spectrometry | Index Medicus | Research & development | Nuclear magnetic resonance | R&D | NMR
Journal Article